Skip to main content
. Author manuscript; available in PMC: 2024 Jul 15.
Published in final edited form as: Urolithiasis. 2022 Mar 2;50(3):303–317. doi: 10.1007/s00240-022-01314-5

Fig. 7.

Fig. 7

A Differential abundance gene analysis; B metabolic pathway enrichment in terms of the number of microbial genes significantly enriched in either the CaOx or Control group. Pathways were chosen for inclusion if either a large number of significantly different genes fit the pathway or the pathway had been previously associated with urolithiasis. *Indicates pathways associated with oxalate metabolism, synthesis, or transport; C Significantly difference genes mapped to de novo constructed genomes